KR102185697B1 - 중간엽 줄기 세포의 분화 방법 - Google Patents

중간엽 줄기 세포의 분화 방법 Download PDF

Info

Publication number
KR102185697B1
KR102185697B1 KR1020207014262A KR20207014262A KR102185697B1 KR 102185697 B1 KR102185697 B1 KR 102185697B1 KR 1020207014262 A KR1020207014262 A KR 1020207014262A KR 20207014262 A KR20207014262 A KR 20207014262A KR 102185697 B1 KR102185697 B1 KR 102185697B1
Authority
KR
South Korea
Prior art keywords
msc
cells
derived cells
derived
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020207014262A
Other languages
English (en)
Korean (ko)
Other versions
KR20200063241A (ko
Inventor
산드라 피에트리
쑤안 마이 누엔
엔리코 바스티아넬리
사브리나 에나
피에르 이브 라뤼엘
이자벨 팃갓
Original Assignee
본 테라퓨틱스 소시에테아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 본 테라퓨틱스 소시에테아노님 filed Critical 본 테라퓨틱스 소시에테아노님
Publication of KR20200063241A publication Critical patent/KR20200063241A/ko
Application granted granted Critical
Publication of KR102185697B1 publication Critical patent/KR102185697B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
KR1020207014262A 2017-10-20 2018-09-25 중간엽 줄기 세포의 분화 방법 Expired - Fee Related KR102185697B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17197605.3 2017-10-20
EP17197605 2017-10-20
PCT/EP2018/076030 WO2019076591A1 (en) 2017-10-20 2018-09-25 METHODS FOR DIFFERENCING MESENCHYMAL STEM CELLS

Publications (2)

Publication Number Publication Date
KR20200063241A KR20200063241A (ko) 2020-06-04
KR102185697B1 true KR102185697B1 (ko) 2020-12-03

Family

ID=60153205

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207014262A Expired - Fee Related KR102185697B1 (ko) 2017-10-20 2018-09-25 중간엽 줄기 세포의 분화 방법

Country Status (13)

Country Link
US (2) US11447749B2 (https=)
EP (1) EP3697894A1 (https=)
JP (1) JP7039711B2 (https=)
KR (1) KR102185697B1 (https=)
CN (1) CN111247240A (https=)
AU (1) AU2018351804B2 (https=)
BE (1) BE1025935A9 (https=)
BR (1) BR112020007775A2 (https=)
CA (1) CA3079439C (https=)
IL (1) IL273987B (https=)
RU (1) RU2020113411A (https=)
SG (1) SG11202003524XA (https=)
WO (1) WO2019076591A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1026595B9 (fr) * 2018-09-25 2020-11-03 Bone Therapeutics Sa Procedes de differenciation de cellules souches mesenchymateuses
CN113648417A (zh) * 2021-03-15 2021-11-16 中国人民解放军军事科学院军事医学研究院 Postn作为调控间充质干细胞分化能力的标志物及其应用
CN113355279A (zh) * 2021-06-07 2021-09-07 深圳市中佳生物医疗科技有限公司 一种人韧带成纤维细胞的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139410A1 (en) * 2002-01-14 2003-07-24 Kiminobu Sugaya Use of modified pyrimidine compounds to promote stem cell migration and proliferation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5972703A (en) 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
CA2640794C (en) 2006-02-16 2015-04-14 Universite Libre De Bruxelles A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
WO2008129563A2 (en) * 2007-04-23 2008-10-30 Stempeutics Research Private Limited, Human mesenchymal stem cells and preparation thereof
US20100278788A1 (en) 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
HK1202581A1 (en) 2012-02-13 2015-10-02 Gamida-Cell Ltd. Mesenchymal stem cells conditioned medium and methods of generating and using the same
EP2943206A4 (en) * 2013-01-12 2017-01-04 Cesca Therapeutics Inc. Rapid infusion of autologous bone marrow derived stem cells
EP3074505B1 (en) 2014-02-14 2018-06-06 National University of Ireland Galway Serum-free medium
JP6446222B2 (ja) * 2014-09-30 2018-12-26 株式会社ジーシー 軟骨分化培養液、及び軟骨組織の製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139410A1 (en) * 2002-01-14 2003-07-24 Kiminobu Sugaya Use of modified pyrimidine compounds to promote stem cell migration and proliferation

Also Published As

Publication number Publication date
BE1025935B9 (fr) 2019-10-29
JP7039711B2 (ja) 2022-03-22
AU2018351804B2 (en) 2020-07-09
JP2020537539A (ja) 2020-12-24
US20230042822A1 (en) 2023-02-09
BE1025935A1 (fr) 2019-08-13
SG11202003524XA (en) 2020-05-28
BE1025935A9 (fr) 2019-11-05
CN111247240A (zh) 2020-06-05
CA3079439A1 (en) 2019-04-25
EP3697894A1 (en) 2020-08-26
US11447749B2 (en) 2022-09-20
US20200354682A1 (en) 2020-11-12
IL273987B (en) 2021-06-30
AU2018351804A1 (en) 2020-05-14
BE1025935B1 (fr) 2019-10-18
RU2020113411A3 (https=) 2021-11-22
IL273987A (en) 2020-05-31
KR20200063241A (ko) 2020-06-04
WO2019076591A1 (en) 2019-04-25
CA3079439C (en) 2022-08-09
RU2020113411A (ru) 2021-11-22
BR112020007775A2 (pt) 2020-10-20

Similar Documents

Publication Publication Date Title
JP4125241B2 (ja) 歯に由来する多能性胚性様幹細胞およびその使用
EP3856894B1 (en) Methods for differentiating mesenchymal stem cells
Karunanithi et al. Three dimensional alginate-fucoidan composite hydrogel augments the chondrogenic differentiation of mesenchymal stromal cells
CN105408361B (zh) 硫酸乙酰肝素
US20090081169A1 (en) Method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
US20230042822A1 (en) Methods for differentiating mesenchymal stem cells
CN103169731A (zh) 用于体内生成、修复和/或维护结缔组织的方法
JP2022061997A (ja) 溶剤／界面活性剤処理された血漿（ｓ／ｄ血漿）を含む製剤及びその使用
Tanaka et al. Growth factor contents of autologous human sera prepared by different production methods and their biological effects on chondrocytes
TW202246491A (zh) 椎間盤再生用組成物
BE1020528A3 (fr) Utilisations du facteur de croissance et differenciation 8 (gdf 8).
TW202104591A (zh) 用於分化間質幹細胞之方法
Pestehei et al. Reconstruction of Trachea Defect by Composite of PLGA/FG Materials with Differentiated Human Adipose-Derived Stem Cells in a Dog Model
Wang Vascularization and osteogenesis in bone physiological processes influenced by bio-active molecules and scaffolds

Legal Events

Date Code Title Description
A302 Request for accelerated examination
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241127

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241127

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241127